$2.08
0.115.58%
Last update: Nov 6, 7:58 PM

The average analyst price target for Altimmune is $17, 721.3% above the current price. Of 13 analysts, 10 rate it Buy and 3 Hold. Targets range from $10 to $25. The latest change came on Sep 23, 2026, when Evercore ISI Group lowered its price target on Altimmune from $18 to $17 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months